Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment
- PMID: 24715559
- PMCID: PMC4314691
- DOI: 10.1002/ajmg.a.36545
Osteogenesis imperfecta: clinical diagnosis, nomenclature and severity assessment
Erratum in
- Am J Med Genet A. 2015 May;167A(5):1178
Abstract
Recently, the genetic heterogeneity in osteogenesis imperfecta (OI), proposed in 1979 by Sillence et al., has been confirmed with molecular genetic studies. At present, 17 genetic causes of OI and closely related disorders have been identified and it is expected that more will follow. Unlike most reviews that have been published in the last decade on the genetic causes and biochemical processes leading to OI, this review focuses on the clinical classification of OI and elaborates on the newly proposed OI classification from 2010, which returned to a descriptive and numerical grouping of five OI syndromic groups. The new OI nomenclature and the pre-and postnatal severity assessment introduced in this review, emphasize the importance of phenotyping in order to diagnose, classify, and assess severity of OI. This will provide patients and their families with insight into the probable course of the disorder and it will allow physicians to evaluate the effect of therapy. A careful clinical description in combination with knowledge of the specific molecular genetic cause is the starting point for development and assessment of therapy in patients with heritable disorders including OI. © 2014 The Authors. American Journal of Medical Genetics Published by Wiley Periodicals, Inc. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
Keywords: classification; collagen type I; fractures; heterogeneity; osteogenesis imperfecta.
© 2014 The Authors. American Journal of Medical Genetics Part A Published by Wiley Periodicals, Inc.
Figures
Similar articles
-
Phenotypic Variation in Vietnamese Osteogenesis Imperfecta Patients Sharing a Recessive P3H1 Pathogenic Variant.Genes (Basel). 2022 Feb 24;13(3):407. doi: 10.3390/genes13030407. Genes (Basel). 2022. PMID: 35327962 Free PMC article.
-
[Genotypes and phenotypes of nine Uygur children with osteogenesis imperfecta in Xinjiang].Zhonghua Er Ke Za Zhi. 2020 Feb 2;58(2):135-139. doi: 10.3760/cma.j.issn.0578-1310.2020.02.013. Zhonghua Er Ke Za Zhi. 2020. PMID: 32102151 Chinese.
-
[Genetic basis for skeletal disease. Osteogenesis imperfecta and genetic abnormalities].Clin Calcium. 2010 Aug;20(8):1190-5. Clin Calcium. 2010. PMID: 20675929 Review. Japanese.
-
What is new in genetics and osteogenesis imperfecta classification?J Pediatr (Rio J). 2014 Nov-Dec;90(6):536-41. doi: 10.1016/j.jped.2014.05.003. Epub 2014 Jul 18. J Pediatr (Rio J). 2014. PMID: 25046257 Review.
-
Classification of osteogenesis imperfecta.Wien Med Wochenschr. 2015 Jul;165(13-14):264-70. doi: 10.1007/s10354-015-0368-3. Epub 2015 Jul 25. Wien Med Wochenschr. 2015. PMID: 26208476 Review.
Cited by
-
TMEM38B Gene Mutation Associated With Osteogenesis Imperfecta.Cureus. 2024 Sep 9;16(9):e69021. doi: 10.7759/cureus.69021. eCollection 2024 Sep. Cureus. 2024. PMID: 39385871 Free PMC article.
-
Dental Abnormalities in Osteogenesis Imperfecta: A Systematic Review.Calcif Tissue Int. 2024 Sep 18. doi: 10.1007/s00223-024-01293-2. Online ahead of print. Calcif Tissue Int. 2024. PMID: 39294450 Review.
-
Clinical, Radiographic, and Biomechanical Evaluation of the Upper Extremity in Patients with Osteogenesis Imperfecta.J Clin Med. 2024 Aug 31;13(17):5174. doi: 10.3390/jcm13175174. J Clin Med. 2024. PMID: 39274387 Free PMC article.
-
Osteogenesis Imperfecta: A study of the patient journey in 13 European countries.Orphanet J Rare Dis. 2024 Sep 9;19(1):331. doi: 10.1186/s13023-024-03345-0. Orphanet J Rare Dis. 2024. PMID: 39252130 Free PMC article.
-
Bone Quality and Mineralization and Effects of Treatment in Osteogenesis Imperfecta.Calcif Tissue Int. 2024 Sep 4. doi: 10.1007/s00223-024-01263-8. Online ahead of print. Calcif Tissue Int. 2024. PMID: 39231826 Review.
References
-
- Alcausin MB, Ault J, Briody J, Pacey V, Mcquade M, Bridge C, Engelbert RHH, Sillence DO, Munns CF. Intravenous pamidronate treatment in children with moderate-to-severe osteogenesis imperfecta started under three years of age. Horm Res Paediatr. 2013;79:333–340. - PubMed
-
- Bailleul-Forestier I, Berdal A, Vinchier F, de Ravel T, Fryns JP, Verloes A. The genetic basis of inherited anomalies of the teeth. Part 2: syndromes with significant dental development. EJMG. 2008;51:383–408. - PubMed
-
- Baljet B. Aspects of the history of osteogenesis imperfecta (Vrolik's syndrome) Ann Anat. 2002;184:1–7. - PubMed
-
- Barnes AM, Chang W, Morello R, Cabral WA, Weis M, Eyre DR, Leikin S, Makareeva E, Kuznetsova N, Uveges TE, Ashok A, Flor AW, Mulvihill JJ, Wilson PL, Sundaram UT, Lee B, Marini JC. Deficiency of cartilage-associated protein in recessive lethal osteogenesis imperfecta. N Engl J Med. 2006;355:2757–2764. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
